Brought to you by 
Microvena acquires IntraTherapeutics for $95mm
16 Nov 2022
Executive Summary
As part of its plan to divest its cardiac and vascular divisions, Centerpulse AG of Zurich has agreed to sell IntraTherapeutics to Microvena (cardiovascular medical devices; also known as ev3 Inc.) for Euro96.6mm ($95mm).
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash for Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Microvena acquires IntraTherapeutics for $95mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice